New data from CREDENCE: SGLT2 inhibitors may improve liver steatosis/fibrosis, data which support further evaluation of this drug class in people with NAFLD @fletcher_RA @jardine_meg @themahaf @bakrisgeorge @arnottclare @VladoPerkovic Free link: